• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非手术联合疗法治疗有色人种患者瘢痕疙瘩的疗效:一项10年随访研究

Outcomes of a Non-Surgical Combination Therapy for Keloids in Skin of Color Patients: A 10-Year Follow-Up Study.

作者信息

Brandão Marina Patrus Ananias de Souza, Vieira Carolina Fernandes Otoni, Rocha Daniel Brasil Braga, Silva Márcio Roberto, da Silva Jussara Aparecida, Gold Michael H, de Oliveira Gisele Viana

机构信息

Post Graduation Department, Medical Sciences Faculty of Minas Gerais (FCMMG), Belo Horizonte, Brazil.

EMBRAPA Gado de Leite, Juiz de Fora, Brazil.

出版信息

Int J Dermatol. 2025 Aug;64(8):1434-1440. doi: 10.1111/ijd.17829. Epub 2025 May 5.

DOI:10.1111/ijd.17829
PMID:40322860
Abstract

BACKGROUND

Keloid treatment remains challenging due to high recurrence rates, particularly in patients with higher phototypes. This study aimed to assess the resolution, patient satisfaction, and recurrence rates in 79 keloids treated with a sequential non-surgical protocol combining long-term occlusion with hydrocolloid dressings, monthly injections of triamcinolone and 5-fluorouracil (5-FU), and intense pulsed light therapy. This approach is expected to lower recurrence, improve resolution, and increase patient satisfaction compared to traditional treatments.

METHODS

This longitudinal observational study included 79 keloids in 55 patients with Fitzpatrick phototypes III or higher. Data were collected retrospectively from medical records and clinical appointments. Patients were followed for 19-123 months after completing treatment. Outcomes evaluated included keloid resolution, patient satisfaction, and recurrence rates.

RESULTS

The patients had a mean age of 39 years and underwent treatment for a median of 10 months. Pain was reported in 8.9% of cases, and only one recurrence (1.3%) occurred five years post-treatment. Complete resolution was achieved in 82.3% of keloids, and 94.9% of patients reported maximum satisfaction.

CONCLUSIONS

The sequential non-surgical approach evaluated in this study demonstrated low recurrence and high satisfaction rates. Thus, it may represent a promising treatment option for keloid patients with higher phototypes.

摘要

背景

由于瘢痕疙瘩复发率高,尤其是在皮肤光类型较高的患者中,瘢痕疙瘩的治疗仍然具有挑战性。本研究旨在评估79例瘢痕疙瘩采用序贯非手术方案治疗后的消退情况、患者满意度和复发率,该方案包括长期使用水胶体敷料封闭、每月注射曲安奈德和5-氟尿嘧啶(5-FU)以及强脉冲光治疗。与传统治疗相比,这种方法有望降低复发率、提高消退率并提高患者满意度。

方法

这项纵向观察性研究纳入了55例皮肤光类型为III型或更高的患者的79个瘢痕疙瘩。数据通过回顾病历和临床预约进行收集。患者在完成治疗后随访19 - 123个月。评估的结果包括瘢痕疙瘩的消退情况、患者满意度和复发率。

结果

患者的平均年龄为39岁,治疗时间中位数为10个月。8.9%的病例报告有疼痛,治疗后五年仅发生1例复发(1.3%)。82.3%的瘢痕疙瘩实现了完全消退,94.9%的患者表示非常满意。

结论

本研究评估的序贯非手术方法显示出低复发率和高满意率。因此,它可能是皮肤光类型较高的瘢痕疙瘩患者的一种有前景的治疗选择。

相似文献

1
Outcomes of a Non-Surgical Combination Therapy for Keloids in Skin of Color Patients: A 10-Year Follow-Up Study.非手术联合疗法治疗有色人种患者瘢痕疙瘩的疗效:一项10年随访研究
Int J Dermatol. 2025 Aug;64(8):1434-1440. doi: 10.1111/ijd.17829. Epub 2025 May 5.
2
Efficacy and safety of intralesional triple combination versus intralesional triamcinolone acetonide for the treatment of keloids: A randomised controlled trial.病灶内三联组合与病灶内注射曲安奈德治疗瘢痕疙瘩的疗效及安全性:一项随机对照试验
Indian J Dermatol Venereol Leprol. 2025 Jul-Aug;91(4):425-431. doi: 10.25259/IJDVL_1263_2024.
3
Laser therapy for treating hypertrophic and keloid scars.激光疗法治疗增生性瘢痕和瘢痕疙瘩。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD011642. doi: 10.1002/14651858.CD011642.pub2.
4
Surgery for trigger finger.扳机指手术
Cochrane Database Syst Rev. 2018 Feb 20;2(2):CD009860. doi: 10.1002/14651858.CD009860.pub2.
5
Long-Term Results of a Multimodal Treatment Regimen in Patients With Auricular Keloids.耳廓瘢痕疙瘩患者多模式治疗方案的长期结果
Ear Nose Throat J. 2025 Aug;104(8):486-492. doi: 10.1177/01455613221133202. Epub 2022 Oct 31.
6
Silicone gel sheeting for treating keloid scars.硅凝胶片治疗瘢痕疙瘩。
Cochrane Database Syst Rev. 2023 Jan 3;1(1):CD013878. doi: 10.1002/14651858.CD013878.pub2.
7
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.治疗寻常型外阴上皮内瘤变的医学和外科干预措施。
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD011837. doi: 10.1002/14651858.CD011837.pub2.
8
Alternative treatment for recurrent keloids: initial clinical experience with Rhenium-188 using a specialized device.复发性瘢痕疙瘩的替代治疗:使用专用设备进行铼-188治疗的初步临床经验。
Eur J Nucl Med Mol Imaging. 2025 Mar 12. doi: 10.1007/s00259-025-07184-4.
9
Comparing the Effect of Intralesional 5-Fluorouracil (5-FU) Alone Versus Intralesional 5-FU Combined With Triamcinolone Acetonide for Keloid Treatment.比较单纯病灶内注射5-氟尿嘧啶(5-FU)与病灶内注射5-氟尿嘧啶联合曲安奈德治疗瘢痕疙瘩的效果。
Cureus. 2025 May 22;17(5):e84635. doi: 10.7759/cureus.84635. eCollection 2025 May.
10
Foam dressings for treating pressure ulcers.用于治疗压疮的泡沫敷料。
Cochrane Database Syst Rev. 2017 Oct 12;10(10):CD011332. doi: 10.1002/14651858.CD011332.pub2.

本文引用的文献

1
Analysis of factors affecting treatment adherence in patients with keloid disease.瘢痕疙瘩病患者治疗依从性的影响因素分析
Arch Dermatol Res. 2025 Feb 12;317(1):390. doi: 10.1007/s00403-025-03849-0.
2
A Comprehensive Review of Non-Surgical Treatments for Hypertrophic and Keloid Scars in Skin of Color.有色人种皮肤增生性瘢痕和瘢痕疙瘩非手术治疗的综合综述
Clin Cosmet Investig Dermatol. 2024 Jun 18;17:1459-1469. doi: 10.2147/CCID.S470997. eCollection 2024.
3
Effect of Keloid Properties on Treatment Efficacy: A Systematic Review.
瘢痕性质对治疗效果的影响:系统评价。
Dermatol Surg. 2024 Oct 1;50(10):913-921. doi: 10.1097/DSS.0000000000004256. Epub 2024 Jun 14.
4
Gender Differences in Post-Operative Human Skin.术后人体皮肤的性别差异
Biomedicines. 2023 Sep 27;11(10):2653. doi: 10.3390/biomedicines11102653.
5
The Detroit Keloid Scale: A Validated Tool for Rating Keloids.底特律瘢痕疙瘩量表:一种瘢痕疙瘩评分的有效工具。
Facial Plast Surg Aesthet Med. 2023 Mar-Apr;25(2):119-125. doi: 10.1089/fpsam.2021.0359. Epub 2022 Apr 7.
6
Treatment of keloids and hypertrophic scars. Position statement of the Brazilian expert group GREMCIQ.瘢痕疙瘩和增生性瘢痕的治疗。巴西专家组 GREMCIQ 的立场声明。
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):2128-2142. doi: 10.1111/jdv.17484. Epub 2021 Jul 15.
7
Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases.单细胞 RNA 测序揭示人类纤维化皮肤疾病中成纤维细胞的异质性和间充质成纤维细胞的增加。
Nat Commun. 2021 Jun 17;12(1):3709. doi: 10.1038/s41467-021-24110-y.
8
A Review of Key Likert Scale Development Advances: 1995-2019.李克特量表发展关键进展综述:1995 - 2019年
Front Psychol. 2021 May 4;12:637547. doi: 10.3389/fpsyg.2021.637547. eCollection 2021.
9
Long-term outcomes and recurrence-free interval after the treatment of keloids with a standardized protocol.采用标准化方案治疗瘢痕疙瘩的长期疗效和无复发生存期。
J Tissue Viability. 2021 Feb;30(1):128-132. doi: 10.1016/j.jtv.2020.11.003. Epub 2020 Nov 30.
10
Assessing keloid recurrence following surgical excision and radiation.评估手术切除和放疗后瘢痕疙瘩的复发情况。
Burns Trauma. 2020 Nov 14;8:tkaa031. doi: 10.1093/burnst/tkaa031. eCollection 2020.